Im not sure your reading is correct. The "second baseline" value is the same as the first baseline in the dmx->pbo cohort. This means their albumin/creatine ratio is the same after 6 weeks dmx wash out as it was at randomisation. Therefore no "legacy effect".
Does this make sense?
Ann: Dimerix Plans for Next Study in Diabetic Kidney Disease, page-10
-
- There are more pages in this discussion • 160 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
50.0¢ |
Change
0.050(11.1%) |
Mkt cap ! $277.8M | |||
| Open | High | Low | Value | Volume |
| 46.0¢ | 50.5¢ | 46.0¢ | $1.817M | 3.735M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 64226 | 49.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.5¢ | 109592 | 2 |
View Market Depth
| Last trade - 14.27pm 12/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |